IPO Pipeline Reopens Into a Liquidity Squeeze

The week of July 27, 2026, is shaping up as the most consequential stretch for new issuance and market structure this year. Four IPOs are on the pricing calendar anchored by Jersey Mike’s $1 billion deal. But the same window brings roughly $120 billion in Treasury bill settlements, a SpaceX lockup cliff that could unlock nearly a billion shares, a dispersion-trade unwind as mega-cap earnings land, and a Federal Reserve decision under a new chair. Each of these is a known event on the calendar. What is less appreciated is how they overlap — and what happens when a revived IPO market meets a system simultaneously draining liquidity from multiple valves.

The IPO Calendar: Four Deals, Four Sectors

Renaissance Capital’s calendar for the week of July 27 lists four deals expected to price, spanning restaurants, fashion, biotech, and digital infrastructure — a breadth that itself signals the IPO window is open wider than it has been in months.^[1]

Jersey Mike’s (JMKE) is the headline deal. The Blackstone-backed sandwich chain plans to raise $1.0 billion by offering 43.5 million shares at $21 to $25, with 68% of the shares sold by existing stockholders. At the midpoint, the company would command a fully diluted market value of roughly $7.3 billion.^[2] The Tinton Falls, New Jersey-based franchisor operates roughly 3,300 locations, the vast majority run by independent franchisees, and booked $742 million in revenue for the trailing twelve months ended March 31, 2026.^[2] The deal is expected to price the week of July 27 and list on the NYSE under the symbol JMKE, making it one of the largest restaurant IPOs on record.^[3]

Reformation (REF) targets a $225 million raise at a $15–$17 range, with a fully diluted valuation approaching $1 billion.^[1] The Los Angeles-based direct-to-consumer womenswear brand reported $507 million in net revenue for 2025 and has filed to list on the NYSE.^[4] Notably, about one-third of the 14.1 million shares are being sold by existing stockholders — a meaningful secondary component that mirrors the structure of the Jersey Mike’s deal.

Apnimed (APMD) is a late-stage biotech developing the first oral pill for obstructive sleep apnea, with an NDA under FDA review and a PDUFA target action date expected in Q1 2027.^[5] The Cambridge, Massachusetts-based company plans to raise $150 million at $14–$16, listing on Nasdaq.^[1] The deal represents a regulatory-binary IPO — pricing the company ahead of an FDA decision that will materially reprice the equity in either direction.

Ionic Digital (IOND) takes a different path: a direct listing on Nasdaq scheduled for July 28, with a reference price of $53 and a potential valuation near $2 billion.^[6] The company was formed in January 2024 from the cryptocurrency mining assets of Celsius Mining’s bankruptcy estate and has since pivoted to position itself as a digital infrastructure provider for AI and high-performance computing.^[6] A direct listing — no underwritten raise, no new capital — means Ionic’s debut is purely about price discovery for existing shares, which makes it a test of market appetite for crypto-adjacent infrastructure stories.

SpaceX: The Lockup Cliff Nobody Can Ignore

While the IPO calendar commands headlines, a far larger supply event is bearing down on the market from SpaceX’s June 12 IPO. SpaceX floated only about 5% of its shares at the $135 IPO price — roughly 629 million shares — compared with the ~20% that a typical IPO sells.^[7] The remaining 95% sits behind what Morningstar calls “the longest series of lock-up releases we’ve ever seen,” as described by Matthew Kennedy, senior strategist at Renaissance Capital.^[7]

The first major tranche unlocks on August 6, 2026 — two business days after SpaceX’s first earnings report as a public company on August 4.^[7] That initial release covers approximately 911.5 million shares, about 20% of locked-up stock.^[8] A second expiration on August 20 releases another 455.8 million shares.^[7] Additional tranches follow through September and beyond, with the total unlock ultimately reaching more than 6.4 billion shares over the first year.^[7]

SpaceX’s stock has already been volatile. After pricing at $135, shares soared above $201 within the first week before falling below the IPO price in mid-July, trading toward $111 — a roughly 45% loss from the peak.^[7] Morningstar analyst Nicolas Owens believes the lockup overhang is “conceivable” as a driver of that decline, noting that “existing sellers have low cost basis and long holding periods” and that “most of the available shares will come to market.”^[7]

The index-fund channel will absorb some of this supply. The Invesco QQQ Trust held roughly 39.7 million SpaceX shares as of July 22, worth $4.57 billion and representing a 0.98% portfolio weight.^[7] As the float-adjusted market cap rises with each unlock, index providers will increase SpaceX’s weight — potentially tripling it by late September if the share count in public hands triples.^[7] But Owens is skeptical that passive flows will be enough: “Unless something changes the fundamental story or sentiment, the supply from these lockups will outweigh demand even from index funds.”^[7]

For market structure, the SpaceX unlock is the dominant near-term supply event. The $123 billion in shares unlocking in early August alone dwarfs the combined $1.4 billion in IPO proceeds expected this week.^[8]

T-Bill Settlements: The Mechanical Liquidity Drain

Even as new issuance arrives, the Treasury is pulling cash out of the system at an accelerating pace. The week of July 27 carries roughly $120 billion in T-bill settlements across three days: $70.5 billion on July 28, $38.5 billion on July 30, and $11.6 billion on July 31.^[9]

The statistical pattern is stark. Since tracking began in November 2025, T-bill settlement dates have seen the S&P 500 rise only 45.7% of the time, with an average decline of about 23 basis points. On non-settlement dates, the index has risen 60% of the time with an average gain of roughly 14 basis points.^[9] The pattern is even more pronounced for the XLK tech sector ETF, which has risen only 45% of the time on settlement dates with an average decline of 41 basis points.^[10]

The liquidity drain is expected to continue building through September. As Michael Kramer of Mott Capital Management notes, “the period between now and the beginning of September, maybe even the first couple of weeks of September, will probably be a fairly difficult stretch for markets,” with a reprieve possible in mid-September before another heavy T-bill issuance period into year-end.^[10]

The Dispersion Trade Unwind

Layered on top of the liquidity drain is a structural shift in the options market. The dispersion trade — a strategy that profits from the gap between individual-stock volatility and index volatility — has been a dominant position through earnings season.^[9] But as mega-cap companies report results, single-stock implied volatilities are declining, narrowing the gap between dispersion and implied correlation.^[9]

SpotGamma noted that the COR1M implied correlation index collapsed below 8, signaling extreme dispersion, before a negative gamma environment amplified price swings late in the week of July 20.^[11] The adjustment is likely to accelerate following results from Microsoft and Meta on July 29, and from Apple and Amazon on July 30.^[9]

Historically, when the dispersion-implied correlation spread narrows, the S&P 500 has tended to underperform.^[9] Goldman Sachs strategist Ben Snider warned on July 27 that cross-stock correlations near record lows could break as midterm elections approach, further pressuring the index-level calm.^[11] A rising 1-day VIX ahead of the July 29 Federal Reserve decision adds another volatility catalyst.^[9]

Secondary Offerings: Follow-On Supply Continues

Beyond the IPO calendar, follow-on issuance remains active. REGENXBIO (RGNX) priced a $100 million public offering on July 17, selling 10 million shares at $9.00 per share plus 1.1 million pre-funded warrants at $8.9999, with gross proceeds of approximately $100 million.^[12] Morgan Stanley, J.P. Morgan, Leerink Partners, and Mizuho served as joint bookrunners.^[12] The gene therapy company’s stock declined on the pricing announcement — a typical reaction to dilutive follow-ons in small-cap biotech.^[12]

The pattern matters for market structure: when follow-on supply and IPO supply arrive simultaneously during a liquidity-draining period, the cumulative effect on market depth can exceed what any single deal suggests. REGENXBIO’s $100 million raise is modest on its own, but it is one of several secondary offerings clearing the system in the same window, and each one competes for the same pool of investable cash that T-bill settlements are simultaneously draining.

River City Bank: A Community Bank Tests the Window

After the four deals pricing this week, Renaissance Capital’s calendar lists River City Bank (RCBC) as the next upcoming IPO.^[1] The Sacramento-based commercial bank plans to raise $136 million by offering 2.8 million shares at $48–$51 on Nasdaq, with Raymond James and KBW as underwriters.^[13] River City Bank reported $6 billion in assets and $74 million in net income on a trailing basis.^[13] A community bank IPO is a different animal from a venture-backed restaurant chain or a biotech binary — it tests whether investors have appetite for slower-growth, steady-earnings stories, or whether the window remains open only for high-profile brands.

What to Watch Next

• Jersey Mike’s pricing and first-day performance (week of July 27): The $1 billion deal size and 68% secondary component make this the benchmark for whether investor demand can absorb large new-issue supply. A weak first-day print would signal that even marquee consumer brands need a discount to clear.
• SpaceX earnings and August 6 lockup expiry: The first earnings report on August 4, followed by the unlock of ~911.5 million shares two business days later, is the single largest supply event on the near-term calendar. Watch for selling pressure and whether index-fund rebalancing absorbs the float expansion.
• T-bill settlement calendar through September: The heaviest stretch of net new settlements runs into early September. The statistical drag on equities — roughly 23 basis points per settlement day on average — is a mechanical headwind that compounds with new-issuance supply.
• Fed decision July 29 and VIX response: A hike or a hawkish hold under the new chair would tighten financial conditions into an already liquidity-constrained window. The 1-day VIX is expected to rise materially ahead of the announcement.
• Dispersion-correlation spread: If the gap between dispersion and implied correlation continues narrowing after Microsoft, Meta, Apple, and Amazon report, the unwind of a crowded options structure could amplify index-level moves at exactly the moment T-bill settlements peak.

The core question is not whether any single one of these events is alarming in isolation. It is whether the IPO market’s revival — real and welcome after a multi-year drought — can hold its footing when the plumbing beneath it is simultaneously pulling liquidity, unlocking supply, and unwinding a crowded volatility structure. The answer arrives over the next ten trading sessions.

FN2 Research provides market commentary and education, not personalized investment advice.

Sources

1. IPO Calendar: Upcoming IPOs & IPO Offerings Calendarrenaissancecapital.com
2. JMKE IPO News - Blackstone-backed sandwich chain Jersey Mike's Subs sets terms for $1.0 b…renaissancecapital.com
3. Jersey Mike's Announces Launch of Initial Public Offeringprnewswire.com
4. Reformation Launches Initial Public Offeringprnewswire.com
5. S-1sec.gov
6. Ionic Digital Announces Effectiveness of Registration Statement and Expected Commencement…ionicdigital.com
7. Why SpaceX’s earnings will likely be followed by a wave of stock salesmorningstar.com.au
8. Why SpaceX’s Earnings Will Likely Be Followed by a Wave of Stock Salesmorningstar.com
9. Liquidity Headwinds Build as Dispersion Trade Begins to Fademottcapitalmanagement.com
10. The Market's Liquidity Drain Is Reaching Its Heaviest Stretchmottcapitalmanagement.com
11. Big tech earnings and FOMC collidespotgamma.com
12. EX-99.1sec.gov
13. RCBC IPO News - California-based River City Bank sets terms for $136 million Nasdaq IPOrenaissancecapital.com